C-path to lead pre-consortium aimed at transforming, accelerating medical product development in alpha-1 antitrypsin deficiency
TUCSON, Ariz., Oct. 6, 2022 — Critical Path Institute (C-Path) today announced that it has recently launched a pre-consortium collaboration with the ...